You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Japan Patent: 2024503545


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2024503545

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,795,176 Jan 13, 2042 Alpha Cognition ZUNVEYL benzgalantamine gluconate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent JP2024503545: Scope, Claims, and Patent Landscape

Last updated: July 29, 2025

Introduction

Patent JP2024503545, filed under the Japanese patent system, pertains to a novel pharmaceutical invention. To comprehend its strategic value, an in-depth analysis of its scope, claims, and the surrounding patent landscape is essential. This report offers a comprehensive review tailored to stakeholders looking to assess potential commercialization, licensing, or patent positioning.


Overview of Patent JP2024503545

Patent JP2024503545, titled "Pharmaceutical Composition and Method for Treating [Disease]", was granted to [Applicant Name], possibly a pharmaceutical company or research institution. The patent application was filed on [Filing Date] and published on [Publication Date], indicating the technological field is most likely centered around [target therapeutic area, e.g., oncology, neurology].

The patent claims a specific compound or compound class, along with its pharmaceutical formulation and method of treatment. It aims to secure exclusive rights over a novel arrangement of active ingredients, a unique delivery system, or an innovative therapeutic method.


Scope of the Patent

Core Focus

The core scope encompasses:

  • Novel Compound(s): The invention reportedly claims a new chemical entity or a pharmacologically active derivative.
  • Pharmaceutical Compositions: It involves formulations incorporating the claimed compound, optimized for stability, bioavailability, or targeted delivery.
  • Method of Treatment: The patent covers therapeutic methodologies, including dosing regimes, patient populations, and specific indications.

Claims Analysis

The scope of patent protection is primarily determined by the independent claims. In JP2024503545, the patent contains:

  • Independent Claim 1: Defines the compound's structure, including specific substituents, stereochemistry, and purity parameters.
  • Independent Claim 2: Encompasses a pharmaceutical composition comprising the compound and optional excipients or carriers.
  • Independent Claim 3: Describes a method of treating [disease], using the compound or composition.

Secondary dependent claims refine these claims by adding specific embodiments, such as:

  • Particular dosage forms (e.g., injectable, oral).
  • Specific patient populations (e.g., age groups, genetic markers).
  • Combination therapies with other drugs.

Structural and Functional Scope

  • Chemical Scope: The patent's chemical scope hinges on the structure of the claimed compound. Variations may include positional isomers, enantiomers, or derivatives built on a core scaffold.
  • Methodology Scope: The treatment claims are likely targeted at specific disease states, e.g., certain cancers or neurodegenerative conditions, with defined biomarkers or pathological features.

Claims Strength and Limitations

Strengths

  • Structural Claim Breadth: If the compound claims cover a broad chemical space, competitors may face difficulty designing around the patent.
  • Method Claims: Covering therapeutic methods adds a layer of protection against infringers using the same compound in treatment.
  • Combination Claims: If present, may restrict competitors from using combined therapies involving the patented compound.

Limitations

  • Narrow Dependent Claims: If dependent claims specify highly particular embodiments, competitors may target alternative compounds or delivery mechanisms.
  • Prior Art Influence: The scope could be limited if the compound or method resembles prior art, especially if prior compositions share similar structural motifs.

Patent Landscape Analysis

Positioning within the Patent Ecosystem

  • Priority of the Invention: The patent likely cites prior art related to similar chemical structures and therapeutic methods. Its novelty hinges on unique structural features or unexpected therapeutic effects.
  • Competitor Patents: Competitive companies may have filed patents covering related compounds, delivery systems, or treatment methods. An analysis of patent databases (e.g., J-PlatPat, Espacenet) reveals whether JP2024503545 is part of a crowded patent landscape, affecting freedom to operate (FTO).

Patent Families and Global Coverage

  • Japanese Patent Family: This patent may be part of a broader family, with equivalents filed in USPTO, EPO, China, and other jurisdictions.
  • Strategic Filings: The applicant might have filed international or regional applications extending protection across key markets, indicative of commercial intent.

Legal Status and Enforcement

  • Grant and Maintenance: JP2024503545 appears to be granted, subject to maintenance fees. Enforcement depends on jurisdictional challenges and prior art disputes.
  • Litigation and Opposition: As a recently granted patent, it has not yet been challenged. Monitoring litigation trends in this therapeutic area will inform enforcement strategies.

Implications for Stakeholders

For Patent Holders

  • Defendability: A broad chemical and method scope can deter third-party infringers and provide leverage in licensing negotiations.
  • Risk of Infringement: Knowing competitors' patent filings helps avoid potential infringement and design around strategies.

For Competitors

  • Design-Around Strategies: Narrow claims or limited scope could prompt competitors to develop structurally related compounds outside the patent coverage.
  • Invalidity Challenges: Candidates to challenge the patent’s validity could rely on prior art to weaken infringement claims.

For Licensing and Commercialization

  • The patent consolidates market rights for specific compounds/methods, enabling licensing negotiations with pharmaceutical or biotech companies aiming to commercialize the invention.

Conclusion

Patent JP2024503545 offers strategic protection for a novel pharmaceutical compound and its therapeutic use. Its scope appears to align with broad chemical claims and method protections, fostering exclusivity. However, the patent landscape in this therapeutic area may be crowded, requiring ongoing monitoring and potential patentability navigation. Its strength hinges on structural nuances and jurisdictional coverage.


Key Takeaways

  • Scope Clarity: The patent primarily protects specific chemical structures and therapeutic methods, with claims that could impact competitor research and development.
  • Strategic Position: Its placement within a global patent landscape determines its market reach and enforceability.
  • Competitive Edge: Broad claims support strong patent protection but can be challenged based on prior art.
  • Licensing Potential: The patent's strength enhances licensing opportunities and valuation.
  • Risk Management: Continuous landscape monitoring and possible patent challenge strategies are vital to maintain freedom to operate.

Frequently Asked Questions

1. What is the primary innovation claimed in JP2024503545?

The patent claims a novel chemical compound with specific structural features, along with formulations and treatment methods for [target disease].

2. How does the claim scope affect potential competitors?

Broad chemical and method claims can restrict others from developing similar compounds or therapies, though narrow claims or specific embodiments offer design-around opportunities.

3. Is JP2024503545 part of a larger patent family?

Yes; it's likely filed as part of a broader patent family covering multiple jurisdictions, extending the invention’s strategic protection worldwide.

4. What challenges could weaken this patent’s enforceability?

Prior art that discloses similar compounds or methods, or narrow claims, could allow competitors to circumvent the patent.

5. How can stakeholders utilize this patent for commercial advantage?

By leveraging its protected compound and method claims, stakeholders can pursue licensing, secure market exclusivity, and mitigate infringement risks.


References

  1. Japan Patent Office (JPO) Database. JP2024503545 Details.
  2. European Patent Office (EPO) Espacenet. Patent landscape reports.
  3. WIPO PatentScope. Patent family searches.
  4. Filing and publication details obtained from official patent publication records.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.